OncoBites (@oncobites) 's Twitter Profile
OncoBites

@oncobites

Cancer professionals & advocates sharing cutting-edge #CancerResearch with non-specialists in bite-sized pieces.

ID: 978704345071054848

linkhttp://oncobites.blog calendar_today27-03-2018 18:44:34

687 Tweet

996 Followers

80 Following

OncoBites (@oncobites) 's Twitter Profile Photo

Statistics show that about 10% of new breast cancer diagnoses in the U.S. represent women under 45 years old. For these young patients, their experience with breast cancer presents unique physical and psychological challenges. Laura Urbina writes. oncobites.blog/2025/05/28/the…

OncoBites (@oncobites) 's Twitter Profile Photo

Could the key to efficient chemotherapy lie in our gut? Read along to find out. Yousra Iftequar writes. oncobites.blog/2025/06/04/can…

OncoBites (@oncobites) 's Twitter Profile Photo

Currently, most cancer treatment options rely on eradicating cancer cells. But what if you could turn cancer cells back into normal cells? Mikayla Sheild writes. oncobites.blog/2025/06/11/can…

OncoBites (@oncobites) 's Twitter Profile Photo

Researchers found that a circuit between the nervous and immune system mediates cancer-associated depression and apathy. This highlights a unique neurobiological relationship between cancer, inflammation and psychiatric depression. Anthony Tao writes. oncobites.blog/2025/06/18/fro…

OncoBites (@oncobites) 's Twitter Profile Photo

Radiopharmaceuticals are drugs containing radioactive substances that can be used to both diagnose and treat cancer. 3 seminal trials have propelled radiopharmaceutical therapy into the mainstream. Bethany Cooper writes. oncobites.blog/2025/06/25/ima…

OncoBites (@oncobites) 's Twitter Profile Photo

KRAS mutations dominate the landscape of many solid tumors, but KRAS has been considered an undruggable target for decades. Since 2021, 6 novel KRAS targeting therapies have been developed & FDA-approved for certain cancer types. Chris Wang writes. oncobites.blog/2025/07/02/tar…

OncoBites (@oncobites) 's Twitter Profile Photo

Cancer is a master in cellular manipulation and survival. In recent years, scientists have discovered that cancer cells can hijack healthy mitochondria from neighboring cells and abuse them for their own gain. Hema Saranya Ilamathi writes. oncobites.blog/2025/07/09/how…

OncoBites (@oncobites) 's Twitter Profile Photo

While uncommon, a good number of individuals have developed cancer while pregnant or shortly after giving birth. There’s no direct correlation between pregnancy and the risk of cancer, so how could this happen? Jessica Desamero, PhD writes. oncobites.blog/2025/07/16/can…

OncoBites (@oncobites) 's Twitter Profile Photo

How exactly is the gut microbiome linked to cancer? Oluoma Vivian Aneke writes. This article includes quotes from Dr. Adeel Khan, a haematologist/oncologist, epidemiologist and assistant professor at the University of Texas Southwestern Medical Center. oncobites.blog/2025/07/23/the…

OncoBites (@oncobites) 's Twitter Profile Photo

A recent study has found that a specific type of immune cell, Vd1-gd T cells, can help predict which patients are more likely to respond favorably to immunotherapy treatments. Joycelyn Ghansah, MA, MPH writes. oncobites.blog/2025/07/30/adv…

OncoBites (@oncobites) 's Twitter Profile Photo

Liquid biopsy is a non-invasive blood-based test that may help increase accessibility to screening & improve early detection of colorectal cancer in younger adults. It may also help to improve outcomes after a cancer diagnosis. Nicole Bowens, PhD writes. oncobites.blog/2025/08/06/cou…

OncoBites (@oncobites) 's Twitter Profile Photo

Taurine is one of the most important ingredients in energy drinks. In a novel study, researchers have found that taurine is not just an additive but rather a key player in the metabolic potential of cancer stem cells. Preeti Prangya Panda writes. oncobites.blog/2025/08/13/do-…

OncoBites (@oncobites) 's Twitter Profile Photo

Want to join us in our mission to make cancer research more accessible? There’s still time! If interested, please fill out our form by Aug. 22. (DM us for the link!)

Want to join us in our mission to make cancer research more accessible? There’s still time! If interested, please fill out our form by Aug. 22. 
(DM us for the link!)
OncoBites (@oncobites) 's Twitter Profile Photo

Vaccines have been recognized as a promising chemotherapeutic instrument. Advances in how we select antigens, as well as new platforms & delivery methods, pave the way for developing more specific & potent cancer vaccines. Mariella Careaga writes. oncobites.blog/2025/08/20/a-s…

OncoBites (@oncobites) 's Twitter Profile Photo

In a recent study, scientists have found a clear presence of immune cells, particularly T cells, in the cranial bones of patients with glioblastoma before surgery. Anna Salamero Boix writes. oncobites.blog/2025/08/27/sku…

OncoBites (@oncobites) 's Twitter Profile Photo

A recent publication illustrates the power of data sharing from tissue and data collected in three clinical trials. Patty Spears writes. oncobites.blog/2025/09/03/pow…

OncoBites (@oncobites) 's Twitter Profile Photo

The dependence of cancer cells on various altered metabolic pathways can be exploited for therapeutic purposes. 1 new therapeutic approach is adipose manipulation transplantation, which can potentially suppress cancer cell proliferation. Colin Ong writes. oncobites.blog/2025/09/10/a-n…

OncoBites (@oncobites) 's Twitter Profile Photo

Researchers at UCLA proposed an interesting approach to CAR-T cell therapy: using focused ultrasound to only activate CAR-T cells within a tumor. Restricting CAR-T cell activity would theoretically limit its off-target & toxic effects. Anthony Tao writes. oncobites.blog/2025/09/17/ult…

OncoBites (@oncobites) 's Twitter Profile Photo

Preclinical oncology imaging is no longer a complementary tool, but an essential component of oncology drug development. Bethany Cooper writes. oncobites.blog/2025/09/24/the…

OncoBites (@oncobites) 's Twitter Profile Photo

And that’s a wrap on our last cycle! OncoBites will be taking a short break from publishing to prepare for the new writing cycle. Thank you to all our contributors and readers so far, and we’ll be back with new content soon!